- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic immunoglobulin light chain amyloidosis
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 4, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-25
DOI
10.1038/s41572-018-0034-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
- (2018) Eli Muchtar et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease
- (2018) Felipe Batalini et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis
- (2018) Vina P. Nguyen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis
- (2018) Efstathios Kastritis et al. BLOOD
- Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis
- (2018) Richa Manwani et al. HAEMATOLOGICA
- Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era
- (2018) Arnt V. Kristen et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
- (2018) Robert A. Kyle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
- (2018) Katie L. Thoren SEMINARS IN HEMATOLOGY
- A chemometric approach for characterization of serum transthyretin in familial amyloidotic polyneuropathy type I (FAP-I) by electrospray ionization-ion mobility mass spectrometry
- (2018) Laura Pont et al. TALANTA
- Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis
- (2018) Efstathios Kastritis et al. Blood Cancer Journal
- Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis
- (2018) Richa Manwani et al. HAEMATOLOGICA
- Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data
- (2018) Tiffany P Quock et al. Journal of Comparative Effectiveness Research
- Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
- (2017) Candida Cristina Quarta et al. EUROPEAN HEART JOURNAL
- Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
- (2017) Ute Hegenbart et al. HAEMATOLOGICA
- Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
- (2017) S Sidana et al. LEUKEMIA
- Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
- (2017) J Flores-Montero et al. LEUKEMIA
- Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis
- (2017) Taxiarchis V. Kourelis et al. MAYO CLINIC PROCEEDINGS
- Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis
- (2017) Hallie I. Geller et al. MAYO CLINIC PROCEEDINGS
- Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance
- (2017) Y Song et al. ONCOGENE
- Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
- (2017) E Kastritis et al. Blood Cancer Journal
- Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
- (2017) A D Wechalekar et al. Blood Cancer Journal
- Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells
- (2017) Esther Imperlini et al. Scientific Reports
- Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission
- (2017) Gunilla T. Westermark et al. Cold Spring Harbor Perspectives in Medicine
- Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up
- (2017) Ute Hegenbart et al. HAEMATOLOGICA
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity
- (2017) Luca Oberti et al. Scientific Reports
- Incidence rate of amyloidosis in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort
- (2016) María Adela Aguirre et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
- (2016) Jean D. Sipe et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation
- (2016) Christopher Dittus et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis
- (2016) E. Kastritis et al. BLOOD
- Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial
- (2016) V. Sanchorawala et al. BLOOD
- Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
- (2016) Taxiarchis V. Kourelis et al. BLOOD
- Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study
- (2016) T. Bochtler et al. BLOOD
- What is new in diagnosis and management of light chain amyloidosis?
- (2016) G. Palladini et al. BLOOD
- Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE
- (2016) Julian D. Gillmore et al. CIRCULATION
- Cell Damage in Light Chain Amyloidosis
- (2016) Marta Marin-Argany et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis
- (2016) NICHOLAS Y. TAN et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction
- (2016) Morie A. Gertz et al. JOURNAL OF CLINICAL ONCOLOGY
- The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains
- (2016) Gareth J. Morgan et al. JOURNAL OF MOLECULAR BIOLOGY
- Walking the tightrope: proteostasis and neurodegenerative disease
- (2016) Justin J. Yerbury et al. JOURNAL OF NEUROCHEMISTRY
- Systemic amyloidosis
- (2016) Ashutosh D Wechalekar et al. LANCET
- Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma
- (2016) M I da Silva Filho et al. LEUKEMIA
- Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
- (2016) E Muchtar et al. LEUKEMIA
- Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
- (2016) H Landau et al. LEUKEMIA
- Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
- (2016) G Merlini et al. LEUKEMIA
- Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis
- (2016) Francesco Salinaro et al. European Heart Journal-Cardiovascular Imaging
- Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
- (2015) Isabelle Lousada et al. ADVANCES IN THERAPY
- Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era
- (2015) M. K. Davis et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Biology of Proteostasis in Aging and Disease
- (2015) Johnathan Labbadia et al. Annual Review of Biochemistry
- Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial
- (2015) Vaishali Sanchorawala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding
- (2015) Luis M. Blancas-Mejía et al. BIOPHYSICAL CHEMISTRY
- Hereditary systemic immunoglobulin light-chain amyloidosis
- (2015) M. D. Benson et al. BLOOD
- A practical approach to the diagnosis of systemic amyloidoses
- (2015) C. Fernandez de Larrea et al. BLOOD
- A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis
- (2015) G. Palladini et al. BLOOD
- A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis
- (2015) Maria T. Cibeira et al. BRITISH JOURNAL OF HAEMATOLOGY
- Leukocyte Cell-Derived Chemotaxin 2-Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics
- (2015) S. H. Nasr et al. Clinical Journal of the American Society of Nephrology
- Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis
- (2015) Francesca Lavatelli et al. FASEB JOURNAL
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
- (2015) Anita D'Souza et al. JOURNAL OF CLINICAL ONCOLOGY
- Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens
- (2015) Tilmann Bochtler et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting monoclonal immunoglobulins in human serum using mass spectrometry
- (2015) John R. Mills et al. METHODS
- Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
- (2015) Duncan B. Richards et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias
- (2015) Taxiarchis V. Kourelis et al. AMERICAN JOURNAL OF HEMATOLOGY
- Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone
- (2014) Tilmann Bochtler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis
- (2014) L. Diomede et al. BLOOD
- A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
- (2014) G. Palladini et al. BLOOD
- Lenalidomide and dexamethasone for systemic AL amyloidosis following prior treatment with thalidomide or bortezomib regimens
- (2014) Shameem Mahmood et al. BRITISH JOURNAL OF HAEMATOLOGY
- A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis
- (2014) R. H. Sayed et al. EUROPEAN HEART JOURNAL
- Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant
- (2014) Rahma Warsame et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics
- (2014) J. A. Vrana et al. HAEMATOLOGICA
- Cardiovascular magnetic resonance for amyloidosis
- (2014) Marianna Fontana et al. HEART FAILURE REVIEWS
- Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis
- (2014) Brendan M. Weiss et al. JOURNAL OF CLINICAL ONCOLOGY
- Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients
- (2014) G Palladini et al. LEUKEMIA
- A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis
- (2014) C P Venner et al. LEUKEMIA
- Proteostasis impairment in protein-misfolding and -aggregation diseases
- (2014) Mark S. Hipp et al. TRENDS IN CELL BIOLOGY
- Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish
- (2013) Shikha Mishra et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Systemic light chain amyloidosis: an update for treating physicians
- (2013) G. Merlini et al. BLOOD
- A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
- (2013) A. D. Wechalekar et al. BLOOD
- Systemic Amyloidosis in England: an epidemiological study
- (2013) Jennifer H. Pinney et al. BRITISH JOURNAL OF HAEMATOLOGY
- Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach
- (2013) G. Palladini et al. HAEMATOLOGICA
- Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis
- (2013) GRACE LIN et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Coexistent Multiple Myeloma or Increased Bone Marrow Plasma Cells Define Equally High-Risk Populations in Patients With Immunoglobulin Light Chain Amyloidosis
- (2013) Taxiarchis V. Kourelis et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis
- (2013) Lauren Gray Gilstrap et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques
- (2013) Wael A. AlJaroudi et al. JOURNAL OF NUCLEAR CARDIOLOGY
- AA-Amyloid is cleared by endogenous immunological mechanisms
- (2012) Sofia N. Nyström et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Amyloidosis in autoinflammatory syndromes
- (2012) Laura Obici et al. AUTOIMMUNITY REVIEWS
- High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center
- (2012) S. B. Tsai et al. BLOOD
- A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis
- (2012) E. Kastritis et al. BLOOD
- Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis
- (2012) A. Dispenzieri et al. BLOOD
- Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
- (2012) S. K. Kumar et al. BLOOD
- What do I need to know about immunoglobulin light chain (AL) amyloidosis?
- (2012) Angela Dispenzieri et al. BLOOD REVIEWS
- Incidence and survival in non-hereditary amyloidosis in Sweden
- (2012) Kari Hemminki et al. BMC PUBLIC HEALTH
- Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
- (2012) M A Gertz et al. BONE MARROW TRANSPLANTATION
- Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial
- (2012) V. Sanchorawala et al. HAEMATOLOGICA
- New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
- (2012) Giovanni Palladini et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
- (2012) Shaji Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Roles of Extracellular Chaperones in Amyloidosis
- (2012) Amy R. Wyatt et al. JOURNAL OF MOLECULAR BIOLOGY
- Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
- (2012) H Landau et al. LEUKEMIA
- On Typing Amyloidosis Using Immunohistochemistry. Detailled Illustrations, Review and a Note on Mass Spectrometry
- (2012) Reinhold P. Linke PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY
- Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis
- (2011) H. K. Meier-Ewert et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide
- (2011) Giovanni Palladini et al. ANNALS OF HEMATOLOGY
- Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)
- (2011) T. Bochtler et al. BLOOD
- Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients
- (2011) M. T. Cibeira et al. BLOOD
- Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis
- (2011) J. E. Ward et al. BLOOD
- Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients
- (2011) S. O. Schonland et al. BLOOD
- The repertoire of light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44
- (2011) V. Perfetti et al. BLOOD
- Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis
- (2011) A. D. Wechalekar et al. HAEMATOLOGICA
- Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study
- (2011) V. Sanchorawala et al. HAEMATOLOGICA
- Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation
- (2011) S. M. S. Herrmann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Solid Organ Transplantation in AL Amyloidosis
- (2010) P. T. Sattianayagam et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay
- (2010) A. V. Kristen et al. BLOOD
- The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis
- (2010) G. Palladini et al. BLOOD
- Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study
- (2010) P. Moreau et al. BLOOD
- Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma
- (2010) Sumit Madan et al. MAYO CLINIC PROCEEDINGS
- Kidney dysfunction during lenalidomide treatment for AL amyloidosis
- (2010) R. Specter et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38 MAPK pathway
- (2010) J. Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease
- (2009) S. Girnius et al. HAEMATOLOGICA
- Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney
- (2009) M. A. Gertz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started